Medical ethics collides with public policy: LVAD for a patient with leukemia.
McCarthy
Patrick M
PM
Division of Cardiothoracic Surgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Lamm
Richard D
RD
Sade
Robert M
RM
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000628:therapy*; D003362:Cost-Benefit Analysis; D003561:Cytarabine / Q000008:administration & dosage; D015276:Health Care Rationing / Q000379:methods; D006353:Heart-Assist Devices / Q000191:economics / Q000941:ethics*; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000009:adverse effects*; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011640:Public Policy; D014481:United States
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D015255:Idarubicin